Comparison of 2 doses of PEG-interferon alfa-2b plus weight based ribavirin for treatment of previously untreated patients with genotype 1 HCV infection

被引：0
|
作者：
Cox, PP [1 ]
Do, H [1 ]
Carithers, RL [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：342A / 342A
页数：1
相关论文
共 50 条
  • [31] Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3
    Mangia, Alessandra
    Bandiera, Franco
    Montalto, Giuseppe
    Mottola, Leonardo
    Piazzolla, Valeria
    Minerva, Nicola
    Pellicelli, Adriano
    Ricci, Giovanni L.
    Cela, Marina
    Carretta, Vito
    Scotto, Gaetano
    Bacca, Donato
    Annicchiarico, Brigida
    Romano, Mario
    Russello, Maurizio
    Barbarini, Giorgio
    Agostinacchio, Ernesto
    Andriulli, Angelo
    JOURNAL OF HEPATOLOGY, 2010, 53 (06) : 1000 - 1005
  • [32] Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alfa-2A and ribavirin
    Andriulli, Angelo
    Cursaro, Carmela
    Cozzolongo, Raffaele
    Iacobellis, Angelo
    Valvano, Maria R.
    Mangia, Alessandro
    Minerva, Nicola
    Bacca, Donato
    Stanzione, Maria
    Scuteri, Alessandro
    Montalto, Giuseppe
    Andreone, Pietro
    HEPATOLOGY, 2007, 46 (04) : 342A - 342A
  • [33] Treatment with Peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia - Reply
    Pozzato, G
    JOURNAL OF HEPATOLOGY, 2005, 43 (04) : 738 - 738
  • [34] PEG-interferon alfa-2b for acute hepatitis C: A review
    Palumbo, Emilio
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (08) : 839 - 843
  • [35] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
    Manns, MP
    McHutchison, JG
    Gordon, SC
    Rustgi, VK
    Shiffman, M
    Reindollar, R
    Goodman, ZD
    Koury, K
    Ling, MH
    Albrecht, JK
    LANCET, 2001, 358 (9286): : 958 - 965
  • [36] Gene expression involving interferon-regulatory innate immunity and resistance to PEG-interferon alfa-2b plus ribavirin treatment in chronic hepatitis C
    Asahina, Yasuhiro
    Izumi, Namiki
    Komatsu, Nobutoshi
    Umeda, Naoki
    Hosokawa, Takanori
    Ueda, Ken
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Itakura, Jun
    Kurosaki, Masayuki
    Uchihara, Masakatsu
    Miyake, Shozo
    HEPATOLOGY, 2006, 44 (04) : 220A - 221A
  • [37] Response-Guided Therapy With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin Reduces Treatment Duration in NaiVE and Peginterferon Alfa-2B/Ribavirin Previous-Treatment-Failure Patients With HCV Genotype 1
    Manns, Michael P.
    Poordad, Fred
    Bacon, Bruce R.
    Bruno, Savino
    Esteban, Rafael
    Silva, Marcelo O.
    Buti, Maria
    Burroughs, Margaret
    Sniukiene, Vilma
    Boparai, Navdeep
    Brass, Cliflord A.
    Albrecht, Janice K.
    Bronowicki, Jean-Pierre
    GASTROENTEROLOGY, 2011, 140 (05) : S942 - S942
  • [38] Open-label study of the safety and efficacy of interferon alfa-2b plus ribavirin for the treatment of HCV infection in HIV patients.
    Li, JJ
    Sanchez, N
    Monteiro, C
    Cubbedge, L
    Lambiase, LR
    HEPATOLOGY, 2001, 34 (04) : 588A - 588A
  • [39] Pegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients
    Taliani, G
    Gemignani, G
    Ferrari, C
    Aceti, A
    Bartolozzi, D
    Blanc, PL
    Capanni, M
    Esperti, F
    Forte, P
    Guadagnino, V
    Mari, T
    Marino, N
    Milani, S
    Pasquazzi, C
    Rosina, F
    Tacconi, D
    Toti, M
    Zignego, AL
    Messerini, L
    Stroffolini, T
    GASTROENTEROLOGY, 2006, 130 (04) : 1098 - 1106
  • [40] Cryoglobulinemia-Related Vasculitis During Effective Anti-HCV Treatment with PEG-Interferon alfa-2b
    T. De Blasi
    D. Aguilar Marucco
    G. Cariti
    A. Maiello
    F. G. De Rosa
    G. Di Perri
    Infection, 2008, 36 : 285 - 287
12345